Thinking, Tinkering, Tooling in Systems Biology

Marx, Vivien
March 2004
Genomics & Proteomics;Mar2004, Vol. 4 Issue 2, p16
Trade Publication
Presents the directing force and motivator for the development of novel tools that can capture and juggle comprehensive data sets in systems biology. Usability of system biology for drug development of tissue engineering; Dynamics of cells and organisms; Factors that formalize looking at and thinking about biological systems. INSET: Systems Biology: A Textbook Case.


Related Articles

  • Trends in biomedical engineering: focus on Genomics and Proteomics. Pattini, Linda; Bertacco, Riccardo; Candiani, Gabriele; Masseroli, Marco; Servi, Stefano // Journal of Applied Biomaterials & Biomechanics;May2011, Vol. 9 Issue 2, p98 

    Genomics is the study of an organism's genome aimed at the functional specification of the different parts of the sequence that comprise the blueprint of the living cell to unveil the mechanisms of the physiology of the cell and its basic, developmental, and tissue-specific processes. Proteomics...

  • Proteomics: biology in the post-genomic era. Brower, Vicki // EMBO Reports;Jul2001, Vol. 2 Issue 7, p558 

    In June 2001, when the Human Genome Project and Celera completed the first maps of the human genome, Francis Collins, head of the government sponsored HGP, warned that only then would the real race begin. Proteomics is more complex by several orders of magnitude than genomics, with no one...

  • Studying the System. Salem, Gustavo // R&D Magazine;Feb2011, Vol. 53 Issue 1, p18 

    The article offers information on new methods and tools that could help life science researchers in understanding the whole biological system. Approaches to biological systems study include the focus on only one aspect such as transcriptomics, genomics and proteomics but scientists believe that...

  • Yeast Genomics and Drug Target Identification. Bharucha, Nikë; Kumar, Anuj // Combinatorial Chemistry & High Throughput Screening;Sep2007, Vol. 10 Issue 8, p618 

    The budding yeast Saccharomyces cerevisiae is well recognized as a preferred eukaryote for the development of genomic technologies and approaches. Accordingly, a sizeable complement of genomic resources has been developed in yeast, and this genomic foundation is now informing a wide variety of...

  • A network view of disease and compound screening. Schadt, Eric E.; Friend, Stephen H.; Shaywitz, David A. // Nature Reviews Drug Discovery;Apr2009, Vol. 8 Issue 4, p286 

    The large-scale generation and integration of genomic, proteomic, signalling and metabolomic data are increasingly allowing the construction of complex networks that provide a new framework for understanding the molecular basis of physiological or pathophysiological states. Network-based drug...

  • Software Needed to See Systems Biology.  // Genomics & Proteomics;Mar2004, Vol. 4 Issue 2, p20 

    Presents computer software tools available to process and analyze data involving molecular interactions. Composition of systems biology; Representation in the software as nodes with intermolecular interactions shown as links between the nodes; Implication on the additional data that can be...

  • Mining metabolites: extracting the yeast metabolome from the literature. Nobata, Chikashi; Dobson, Paul; Iqbal, Syed; Mendes, Pedro; Tsujii, Jun'ichi; Kell, Douglas; Ananiadou, Sophia // Metabolomics;Mar2011, Vol. 7 Issue 1, p94 

    Text mining methods have added considerably to our capacity to extract biological knowledge from the literature. Recently the field of systems biology has begun to model and simulate metabolic networks, requiring knowledge of the set of molecules involved. While genomics and proteomics...

  • Comprehensive characterization of malignant phyllodes tumor by whole genomic and proteomic analysis: biological implications for targeted therapy opportunities. Jardim, Denis L. Fontes; Conley, Anthony; Subbiah, Vivek // Orphanet Journal of Rare Diseases;2013, Vol. 8 Issue 1, p1 

    Background: Phyllodes tumors are uncommon breast tumors that account for less than 0.5% of all breast malignancies. After metastases develop, the prognosis is poor, with very few patients living more than 1 year. The biology of this unusual cancer is not understood and,...

  • Neutrophil Proteome: Lessons from Different Standpoints. Morris, C. F. M.; Castro, M. S.; Fontes, W. // Protein & Peptide Letters;Sep2008, Vol. 15 Issue 9, p995 

    The present review brings a timeline of some of the major steps given throughout the years towards the development of our knowledge regarding the biology of the neutrophil. The contribution of early articles and their elementary biochemical approach is highlighted. The importance of the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics